TB Testing Services

Description

The Trust requires the provision of an Interferon Gamma Release Assay (IGRA) testing service for the detection of Mycobacterium tuberculosis infection using the T-SPOT.TB assay, which is the Trust's established standard referred test for Tuberculosis (TB) screening and diagnosis support. Based on current activity levels, the estimated annual demand is approximately 2,820 T-SPOT.TB tests. This volume is indicative only and does not constitute a guaranteed commitment. The contract will ensure continuity of a reliable, high-quality referred testing service that delivers accurate and timely results to support patient diagnosis, treatment decisions and infection control requirements.